115 related articles for article (PubMed ID: 11039189)
21. omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists.
Tozer MJ; Buck IM; Cooke T; Kalindjian SB; Pether MJ; Steel KI
Bioorg Med Chem; 2002 Feb; 10(2):425-32. PubMed ID: 11741790
[TBL] [Abstract][Full Text] [Related]
22. Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.
Sasse A; Ligneau X; Rouleau A; Elz S; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2002 Aug; 45(18):4000-10. PubMed ID: 12190321
[TBL] [Abstract][Full Text] [Related]
23. Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives.
Tosco P; Bertinaria M; Di Stilo A; Cena C; Sorba G; Fruttero R; Gasco A
Bioorg Med Chem; 2005 Aug; 13(15):4750-9. PubMed ID: 15946850
[TBL] [Abstract][Full Text] [Related]
24. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
Pelloux-Léon N; Fkyerat A; Piripitsi A; Tertiuk W; Schunack W; Stark H; Garbarg M; Ligneau X; Arrang JM; Schwartz JC; Ganellin CR
J Med Chem; 2004 Jun; 47(12):3264-74. PubMed ID: 15163206
[TBL] [Abstract][Full Text] [Related]
25. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
[TBL] [Abstract][Full Text] [Related]
26. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
Meier G; Krause M; Hüls A; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
J Med Chem; 2004 May; 47(10):2678-87. PubMed ID: 15115409
[TBL] [Abstract][Full Text] [Related]
27. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of novel 2-(1H-imidazol-4-yl)cyclopropane carboxylic acids: key intermediates for H3 histamine receptor ligands.
Braña MF; Guisado C; Fernando Alguacil L; Garrido E; Pérez-García C; Ruiz-Gayo M
Bioorg Med Chem Lett; 2002 Dec; 12(24):3561-3. PubMed ID: 12443776
[TBL] [Abstract][Full Text] [Related]
29. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
Zhang M; Ballard ME; Pan L; Roberts S; Faghih R; Cowart M; Esbenshade TA; Fox GB; Decker MW; Hancock AA; Rueter LE
Brain Res; 2005 May; 1045(1-2):142-9. PubMed ID: 15910772
[TBL] [Abstract][Full Text] [Related]
30. Novel H3 receptor antagonists. Sulfonamide homologs of histamine.
Wolin R; Connolly M; Afonso A; Hey JA; She H; Rivelli MA; Willams SM; West RE
Bioorg Med Chem Lett; 1998 Aug; 8(16):2157-62. PubMed ID: 9873505
[TBL] [Abstract][Full Text] [Related]
31. Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.
Tedford CE; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Handley MK; Yates SL
J Pharmacol Exp Ther; 1999 May; 289(2):1160-8. PubMed ID: 10215700
[TBL] [Abstract][Full Text] [Related]
32. Different antagonist binding properties of human and rat histamine H3 receptors.
Stark H; Sippl W; Ligneau X; Arrang JM; Ganellin CR; Schwartz JC; Schunack W
Bioorg Med Chem Lett; 2001 Apr; 11(7):951-4. PubMed ID: 11294398
[TBL] [Abstract][Full Text] [Related]
33. General construction pattern of histamine H3-receptor antagonists: change of a paradigm.
Stark H; Ligneau X; Arrang JM; Schwartz JC; Schunack W
Bioorg Med Chem Lett; 1998 Aug; 8(15):2011-6. PubMed ID: 9873477
[TBL] [Abstract][Full Text] [Related]
34. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
[TBL] [Abstract][Full Text] [Related]
35. Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists.
Kathmann M; Schlicker E; Marr I; Werthwein S; Stark H; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):623-7. PubMed ID: 9879720
[TBL] [Abstract][Full Text] [Related]
36. Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE.
De Esch IJ; Mills JE; Perkins TD; Romeo G; Hoffmann M; Wieland K; Leurs R; Menge WM; Nederkoorn PH; Dean PM; Timmerman H
J Med Chem; 2001 May; 44(11):1666-74. PubMed ID: 11356102
[TBL] [Abstract][Full Text] [Related]
37. Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.
Kieć-Kononowicz K; Wiecek M; Sasse A; Ligneau X; Elz S; Ganellin CR; Schwartz JC; Stark H; Schunack W
Pharmazie; 2000 May; 55(5):349-55. PubMed ID: 11828613
[TBL] [Abstract][Full Text] [Related]
38. An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration.
Liu H; Kerdesky FA; Black LA; Fitzgerald M; Henry R; Esbenshade TA; Hancock AA; Bennani YL
J Org Chem; 2004 Jan; 69(1):192-4. PubMed ID: 14703397
[TBL] [Abstract][Full Text] [Related]
39. From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H3-receptor antagonists.
Tozer MJ; Harper EA; Kalindjian SB; Pether MJ; Shankley NP; Watt GF
Bioorg Med Chem Lett; 1999 Jul; 9(13):1825-30. PubMed ID: 10406649
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.
Stocking EM; Miller JM; Barbier AJ; Wilson SJ; Boggs JD; McAllister HM; Wu J; Lovenberg TW; Carruthers NI; Wolin RL
Bioorg Med Chem Lett; 2007 Jun; 17(11):3130-5. PubMed ID: 17412583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]